1700 Broadway, 9th Floor
New York, NY 10019 646.434.4500
Please e-mail us if you would
like more information:
info@crf.org
Heart disease remains the number one cause of death globally and affects millions around the world. The Cardiovascular Research Foundation® (CRF®) is one of the world's leading nonprofit organizations dedicated to interventional cardiology innovation, research, and education. For more than 30 years, we have been helping doctors improve survival and quality of life for people with heart and vascular disease. Our signature scientific symposium is the Transcatheter Cardiovascular Therapeutics® (TCT®) conference, the world's premier meeting in interventional cardiovascular medicine.
Now in its 16th year, our annual fundraiser has become a hallmark event of the holiday season, drawing hundreds of luminaries in cardiovascular medicine and other medical disciplines, as well as high-ranking leaders in government, business, and the community who are passionate about improving treatment for patients with heart and vascular disease. Funds raised at The Annual Pulse of the City Gala® allow CRF® to pursue innovative areas of research, train tomorrow’s physician leaders, and educate the medical community and public about heart health. A portion of these funds will be dedicated to supporting the CRF® Fellowship Program designed to cultivate the next generation of leaders in interventional cardiology research and innovation.
For driving positive change, pioneering innovative methods to enhance health care access and equity, or significantly impacting patient quality of life.
Read More >
Dr. Mariell Jessup is an internationally renowned thought leader in heart failure research, prevention, and treatment. Her groundbreaking work has advanced cardiovascular medicine and played a pivotal role in heart failure and transplant cardiology becoming a certified secondary subspecialty. As the Chief Science and Medical Officer of the American Heart Association (AHA), Dr. Jessup leads the AHA's scientific initiatives and medical strategy.
For an exceptional leader who demonstrates unwavering commitment to perform at an elevated standard of excellence.
Read More >
Michael A. Mussallem, former chairman and CEO of Edwards Lifesciences, is a widely respected industry icon known for his dynamic leadership in patient-focused medical innovations, including transformative therapies like transcatheter heart valves. His dedication to patient care, philanthropy, and corporate responsibility, alongside his leadership roles in prominent health organizations, underscores his exceptional contributions to healthcare.
For embodying a pioneering spirit, continually pushing the boundaries of innovation, and advancing the frontiers of medical technology and patient care.
Read More >
Dr. Peter Fitzgerald is an accomplished inventor, entrepreneur, and investment fund founder, uniquely blending his expertise as an interventional cardiologist and engineer. His pioneering work spans clinical trials, publications, and the founding of numerous medical device companies, advancing patient care and innovation worldwide. He is also known for his mentorship, guiding and inspiring the next generation of medical professionals and innovators.
Thank you for your interest in supporting our signature fundraiser. Proceeds benefit the medical research and educational programs of CRF®. A portion of these funds will be dedicated to supporting the CRF® Fellowship Program designed to cultivate the next generation of leaders in interventional cardiology research and innovation. Your contribution makes a significant difference in the care of people with heart disease by allowing us to pursue innovative areas of research, train tomorrow's physician leaders, and educate the medical community and the public about heart health. We are deeply grateful for your support.
Reserve a table or purchase tickets using the online form below.
You can make a secure, tax-deductible donation today to CRF® – whether you are able to attend the gala or not.
CRF® offers several underwriting opportunities for the gala. To learn how you can become a sponsor, contact Irma Damhuis at 646-434-4690 or idamhuis@crf.org.
Premier ($60,000) Includes one table for 10 with premier seating plus five additional individual tickets, special recognition during program, recognition on digital signage, table recognition signs, complimentary Gold digital ad on event screens, name listed in digital save-the-date and digital Invitation, and logo on Gala website.
Leadership ($40,000) Includes one table for 10 with premium seating, special thanks announcement during program, complimentary Silver digital ad on event screens, and recognition on digital signage.
Benefactor ($30,000) Includes one table for 10, complimentary Bronze digital ad on event screens, and recognition on digital signage.
Patron ($3,000)Includes preferred seating for one person and recognition on digital signage.
Individual ($2,000)Includes seating for one person.
Fellows If you're a fellow interested in attending the Gala or would like to donate a ticket to a fellow, please contact us for details on special pricing.
Digital Advertisement ($4,000)Please contact Judy Romero at 646-434-4608 or jromero@crf.org.
For an exceptional leader who demonstrates unwavering commitment to perform at an elevated standard of excellence.
Read More >
Dr. Jessica L. Mega is co-founder of Verily, one of the most impactful and future-determining technology companies that is applying artificial intelligence and data science to accelerate evidence-generation and enable more precise interventions to improve patient outcomes. Verily is part of the Alphabet family of companies, which includes Google.
For an exceptional individual whose commitment to multidisciplinary collaboration and mentorship in medicine has set new standards for patient care and innovation.
Read More >
A pioneer in the catheter-based treatment of neurovascular diseases including stroke, Dr. L. Nelson (Nick) Hopkins introduced the subspecialty of endovascular neurosurgery in the United States. He also spearheaded one of the world’s largest and most respected stroke centers where innovative methods were developed to treat patients with acute ischemic stroke.
For demonstrating leadership, effecting positive change, adopting innovative methods to improve access to care, or making an exceptional impact on health care delivery and patient quality of life.
Read More >
Collaboration and innovation. Those are the bywords for Michael Jaff's career. He is driven by the incredible shift in thought and the massive potential for impact in the evolution of treatment for peripheral vascular diseases from surgical-based to minimally invasive treatment.
On behalf of the JADA® System/Organon
Awarded to a program that creates innovative uses for emerging technologies.
Read More >
On behalf of the JADA® System/Organon
Even in the 21st century, a significant number of women die in childbirth. One of the major causes is postpartum hemorrhage — heavy, hard-to-control bleeding that can occur without warning. The World Health Organization (WHO) estimates that 14 million cases of PPH occur globally each year, which in some cases may result in major complications.
Thank you to our generous sponsors for supporting The Annual Pulse of the City Gala®.
We are deeply grateful for your support.
For over 30 years, CRF® has been dedicated to helping doctors improve the survival and quality of life for people suffering from heart and vascular disease.
No other organization combines cutting-edge preclinical and clinical research with exceptional medical education to achieve one practical goal: to get better therapies into doctors' hands quickly. By covering all aspects of the research continuum, we're able to accelerate the speed that breakthrough therapies reach patients through doctors, so patients everywhere can live longer, healthier lives.
We need your help to accelerate our efforts so that more people can benefit from the medical advances being made each day. Together, we can give millions of people around the world hope for a brighter, healthier future.
Juan F. Granada, MD
Eric B. Woldenberg, Esq - Chairman